Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases

Tian Wang1, Mingjie Liu1, Xinyu Li1

  • 1Key Lab of Chemical Biology (MOE), Shandong Engineering Research Center for Traditional Chinese Medicine Standard, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.

PubMed

Insights

Persistent oxidative stress drives chronic diseases. This review details the Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, its activators, and natural compounds modulating Nrf2 for disease prevention and treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Persistent oxidative stress is a key factor in numerous chronic diseases, including cancer, neurodegenerative, cardiovascular, kidney, liver, and pulmonary conditions.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a critical regulator of cellular responses to oxidative stress and inflammation.
  • Natural products represent a valuable source for identifying novel therapeutic agents.

Purpose of the Study:

  • To review the current understanding of the Nrf2 pathway.
  • To examine Nrf2 activators that have progressed to clinical trials.
  • To highlight naturally-derived Nrf2 modulators discovered since 2014 and their therapeutic potential in chronic diseases.

Main Methods:

  • Comprehensive literature review of scientific databases.
  • Analysis of clinical trial data for Nrf2 activators.
  • Systematic evaluation of naturally-derived Nrf2 modulators and their reported effects.

Main Results:

  • The Nrf2 pathway is a significant target for mitigating oxidative stress and inflammation.
  • Several Nrf2 activators are under investigation in clinical trials for various diseases.
  • Numerous natural compounds have demonstrated Nrf2-modulating activity, offering potential therapeutic benefits.

Conclusions:

  • The Nrf2 pathway is a promising therapeutic target for a wide range of chronic diseases.
  • Natural products offer a rich resource for developing novel Nrf2-targeting drugs.
  • Further research into naturally-derived Nrf2 modulators could lead to new preventative and treatment strategies.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.3K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
5